Matt Hewitt
Analyst, Craig-Hallum Capital Group
Replay available
Champions Oncology, Inc. (NASDAQ: CSBR) Q4 2025 earnings conference call, held 2025-07-23. Replay captured from the company's public earnings webcast.

Analyst, Craig-Hallum Capital Group
Chief Executive Officer
Chief Financial Officer
Private Investor
Watch the replay and follow the connected company analysis, news, and investor updates for Champions Oncology, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.279 Welcome to the Champions Oncology fourth quarter fiscal year 2025 earnings call. 00:00:05.279 -- 00:00:08.224 At this time, all participants are in a listen-only mode. 00:00:08.224 -- 00:00:11.489 A question and answer session will follow the formal presentation. 00:00:11.489 -- 00:00:15.135 If anyone should require operator assistance during the conference, please press star 00:00:15.135 -- 00:00:19.562 zero on your telephone keypad. Please note, this conference is being recorded. 00:00:19.562 -- 00:00:24.870 I will now turn the conference over to your host, Ronnie Morris, Chief Executive Officer. 00:00:24.870 -- 00:00:27.111 You may begin. 00:00:30.862 -- 00:00:34.365 Good afternoon. I am Ronnie Moore, CEO of Champions Oncology. 00:00:34.365 -- 00:00:37.709 Joining me today is David Miller, our Chief Financial Officer. 00:00:37.709 -- 00:00:40.712 Thank you for joining us for our quarterly earnings call. 00:00:40.712 -- 00:00:44.335 Before I begin, I will remind you that we will be making forward-looking statements during 00:00:44.335 -- 00:00:49.200 today's call and that actual results could differ materially from those indicated. 00:00:49.200 -- 00:00:54.205 Additional information on risk factors can be found in our Form 10-Q and Form 10-K filings. 00:00:54.205 -- 00:00:58.989 A reconciliation of non-GAAP financial measures to GAAP financial measures is available 00:00:58.989 -- 00:01:01.051 in our earnings release. 00:01:01.051 -- 00:01:04.275 Looking back, fiscal 2025 00:01:04.275 -- 00:01:09.501 may ultimately be seen as a pivotal year for Champion's Oncology, one marked by renewed 00:01:09.501 -- 00:01:14.186 momentum, strategic execution, and foundational growth. 00:01:14.186 -- 00:01:19.553 Following a challenging fiscal ...